Sun Ho

Title: Sun Ho - Innovator in Cancer Treatment

Introduction

Sun Ho is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing anti-α5β1 antibodies to inhibit cancer cell proliferation, showcasing his commitment to advancing medical science.

Latest Patents

Sun Ho holds a patent for the invention titled "Use of anti-α5β1 antibodies to inhibit cancer cell proliferation." This patent describes methods for directly killing cancer cells that express α5β1 on their surface. The method involves contacting these cancer cells with anti-α5β1 antibodies, leading to the induction of cell death. This invention is particularly valuable as it can be employed at early stages of cancer development to prevent tumor establishment. Additionally, it can be used to treat previously formed tumors, especially in cases where traditional anti-angiogenesis therapies have proven ineffective. The methods may also be utilized in combination with cancer chemotherapeutic agents or other molecular-based cancer therapeutic agents.

Career Highlights

Throughout his career, Sun Ho has worked with prominent companies in the biotechnology sector, including Facet Biotech Corporation and Abbott Biotherapeutics Corp. His experience in these organizations has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Sun Ho's notable coworkers include Vanitha Ramakrishnan and Vinay Bhaskar. Their collaborative efforts have contributed to the advancement of cancer treatment methodologies.

Conclusion

Sun Ho's innovative work in cancer treatment through the use of anti-α5β1 antibodies represents a significant advancement in medical science. His contributions have the potential to improve patient outcomes and provide new avenues for cancer therapy.